Literature DB >> 2961393

Heberden oration 1986. Complement--friend or foe?

P J Lachmann1.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2961393     DOI: 10.1093/rheumatology/26.6.409

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


× No keyword cloud information.
  11 in total

Review 1.  Molecular mechanisms of complement component C6 deficiency; a hypervariable exon 6 region responsible for three of six reported defects.

Authors:  A Orren
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

Review 2.  Deficiencies of the complement MAC II gene cluster (C6, C7, C9): is subtotal C6 deficiency of particular evolutionary benefit?

Authors:  R Würzner
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  High prevalence of complement component C6 deficiency among African-Americans in the south-eastern USA.

Authors:  Z Zhu; T P Atkinson; K T Hovanky; S B Boppana; Y L Dai; P Densen; R C Go; J S Jablecki; J E Volanakis
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

4.  The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.

Authors:  Y M Lucisano Valim; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

Review 5.  Autoimmunity and the pathogenesis of glomerulonephritis.

Authors:  D B Oliveira; D K Peters
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

6.  Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): report of a case with other autoimmune manifestations.

Authors:  Tina Mahajan; Richard C Merriman; Marvin J Stone
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

7.  Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.

Authors:  P A Gatenby; J E Barbosa; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

8.  Idiopathic peripheral gangrene in Nigeria.

Authors:  A A Adogu; C U Abengove
Journal:  J Natl Med Assoc       Date:  1993-07       Impact factor: 1.798

9.  An anti-peptide antibody that recognizes a neo-antigen in the CR1 stump remaining on erythrocytes after proteolysis.

Authors:  J E Barbosa; R A Harrison; P J Barker; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

10.  Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE).

Authors:  O G Segurado; A A Arnaiz-Villena; P Iglesias-Casarrubios; J Martinez-Laso; J L Vicario; G Fontan; M Lopez-Trascasa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.